156 related articles for article (PubMed ID: 18781149)
1. Estimation of renal function and its potential impact on carboplatin dosing in children with cancer.
Chinnaswamy G; Cole M; Boddy AV; Keir M; Price L; Parry A; English M; Veal GJ;
Br J Cancer; 2008 Sep; 99(6):894-9. PubMed ID: 18781149
[TBL] [Abstract][Full Text] [Related]
2. Investigating current practices in renal function measurement and carboplatin dosing in children with cancer - a UK perspective.
Roberts E; Mogg JAW; Barnfield M; Veal GJ
Pediatr Hematol Oncol; 2020 Apr; 37(3):235-244. PubMed ID: 31941404
[TBL] [Abstract][Full Text] [Related]
3. Reference ranges for 51Cr-EDTA measurements of glomerular filtration rate in children.
Blake GM; Gardiner N; Gnanasegaran G; Dizdarevic S
Nucl Med Commun; 2005 Nov; 26(11):983-7. PubMed ID: 16208176
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.
Millward MJ; Webster LK; Toner GC; Bishop JF; Rischin D; Stokes KH; Johnston VK; Hicks R
Aust N Z J Med; 1996 Jun; 26(3):372-9. PubMed ID: 8811211
[TBL] [Abstract][Full Text] [Related]
5. Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function.
Adamson PC; Veal GJ; Womer RB; Meany HJ; Bernhardt MB; Frazier AL; Balis FM
Pediatr Blood Cancer; 2019 Jun; 66(6):e27672. PubMed ID: 30767382
[TBL] [Abstract][Full Text] [Related]
6. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
Shepherd ST; Gillen G; Morrison P; Forte C; Macpherson IR; White JD; Mark PB
Eur J Cancer; 2014 Mar; 50(5):944-52. PubMed ID: 24445148
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group.
Newell DR; Pearson AD; Balmanno K; Price L; Wyllie RA; Keir M; Calvert AH; Lewis IJ; Pinkerton CR; Stevens MC
J Clin Oncol; 1993 Dec; 11(12):2314-23. PubMed ID: 8246021
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.
Duong JK; Veal GJ; Nath CE; Shaw PJ; Errington J; Ladenstein R; Boddy AV
Br J Clin Pharmacol; 2019 Jan; 85(1):136-146. PubMed ID: 30261554
[TBL] [Abstract][Full Text] [Related]
9. Flat dosing of carboplatin is justified in adult patients with normal renal function.
Ekhart C; de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
Clin Cancer Res; 2006 Nov; 12(21):6502-8. PubMed ID: 17085665
[TBL] [Abstract][Full Text] [Related]
10. Prospective validation of renal function-based carboplatin dosing in children with cancer: A United Kingdom Children's Cancer Study Group Trial.
Thomas H; Boddy AV; English MW; Hobson R; Imeson J; Lewis I; Morland B; Pearson AD; Pinkerton R; Price L; Stevens M; Newell DR
J Clin Oncol; 2000 Nov; 18(21):3614-21. PubMed ID: 11054434
[TBL] [Abstract][Full Text] [Related]
11. Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.
Cathomas R; Klingbiel D; Geldart TR; Mead GM; Ellis S; Wheater M; Simmonds P; Nagaraj N; von Moos R; Fehr M
Ann Oncol; 2014 Aug; 25(8):1591-7. PubMed ID: 24669017
[TBL] [Abstract][Full Text] [Related]
12. Adaptive dosing and platinum-DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours.
Veal GJ; Errington J; Tilby MJ; Pearson AD; Foot AB; McDowell H; Ellershaw C; Pizer B; Nowell GM; Pearson DG; Boddy AV;
Br J Cancer; 2007 Mar; 96(5):725-31. PubMed ID: 17299395
[TBL] [Abstract][Full Text] [Related]
13. Reference data for 51Cr-EDTA measurements of the glomerular filtration rate derived from live kidney donors.
Grewal GS; Blake GM
Nucl Med Commun; 2005 Jan; 26(1):61-5. PubMed ID: 15604949
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
de Lemos ML; Hsieh T; Hamata L; Levin A; Swenerton K; Djurdjev O; Vu T; Hu F; Conklin J; Malfair Taylor SC
Gynecol Oncol; 2006 Dec; 103(3):1063-9. PubMed ID: 16875719
[TBL] [Abstract][Full Text] [Related]
15. Derivation of new equations to estimate glomerular filtration rate in pediatric oncology patients.
Millisor VE; Roberts JK; Sun Y; Tang L; Daryani VM; Gregornik D; Cross SJ; Ward D; Pauley JL; Molinelli A; Brennan RC; Stewart CF
Pediatr Nephrol; 2017 Sep; 32(9):1575-1584. PubMed ID: 28573537
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin dosing in children: calculation by different formulae.
Würthwein G; Krefeld B; Gerss J; Boos J
Onkologie; 2011; 34(1-2):16-22. PubMed ID: 21346380
[TBL] [Abstract][Full Text] [Related]
17. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
Donahue A; McCune JS; Faucette S; Gillenwater HH; Kowalski RJ; Socinski MA; Lindley C
Cancer Chemother Pharmacol; 2001 May; 47(5):373-9. PubMed ID: 11391850
[TBL] [Abstract][Full Text] [Related]
18. Measuring glomerular filtration rate using 51Cr-EDTA: body surface area normalization before or after Bröchner-Mortensen correction?
Pottel H; Hoste L; De Waele L; Braat E; Baete K; Goffin K; Levtchenko E; Gheysens O
Nucl Med Commun; 2014 Nov; 35(11):1150-5. PubMed ID: 25144564
[TBL] [Abstract][Full Text] [Related]
19. Reassessment of a classical single injection 51Cr-EDTA clearance method for determination of renal function in children and adults. Part II: Empirically determined relationships between total and one-pool clearance.
Brøchner-Mortensen J; Jødal L
Scand J Clin Lab Invest; 2009; 69(3):314-22. PubMed ID: 19191067
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer.
Shimokata T; Ando Y; Yasuda Y; Hamada A; Kawada K; Saito H; Matsuo S; Kondo M; Imaizumi K; Hasegawa Y
Cancer Sci; 2010 Dec; 101(12):2601-5. PubMed ID: 20860621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
